We serve Chemical Name:3-amino-2-methylpropanoic acid,hydrate CAS:214139-20-5 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:3-amino-2-methylpropanoic acid,hydrate
CAS.NO:214139-20-5
Synonyms:3-Amino-2-methyl-propionic acid hydrate;DL-3-AMINOISOBUTYRIC ACID MONOHYDRATE;3-Amino-2-methylpropanoic acid hydrate;DL-3-Aminoisobutyric acid hydrate
Molecular Formula:C4H11NO3
Molecular Weight:121.13500
HS Code:2922499990
Physical and Chemical Properties:
Melting point:177-181ºC
Boiling point:326.2ºC at 760mmHg
Density:N/A
Index of Refraction:
PSA:72.55000
Exact Mass:121.07400
LogP:0.30180
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 3-Amino-2-methyl-propionic acid hydrate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,DL-3-Aminoisobutyric acid hydrate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,3-Amino-2-methylpropanoic acid hydrate Use and application,3-Amino-2-methylpropanoic acid hydrate technical grade,usp/ep/jp grade.
Related News: With the advancement of supply-side structural reforms, the production of bulk APIs in China will become more concentrated, and the technology will be further improved. 3-amino-2-methylpropanoic acid,hydrate manufacturer With the advancement of supply-side structural reforms, the production of bulk APIs in China will become more concentrated, and the technology will be further improved. 3-amino-2-methylpropanoic acid,hydrate supplier In October 2020, the Trump administration ordered $375 million worth of Lilly’s COVID-19 antibody therapy bamlanivimab, which is manufactured at the Branchburg plant. 3-amino-2-methylpropanoic acid,hydrate vendor Drug manufacturers make medicines by mixing APIs and pharmaceutical excipients. 3-amino-2-methylpropanoic acid,hydrate factory With the advancement of supply-side structural reforms, the production of bulk APIs in China will become more concentrated, and the technology will be further improved.
